DocMorris AG (OTCMKTS:ZRSEF) Short Interest Up 724.0% in July

DocMorris AG (OTCMKTS:ZRSEF) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 643,190 shares, a growth of 724.0% from the June 30th total of 78,057 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of DocMorris from a “hold” rating to a “buy” rating in a research report on Monday, July 13th. UBS Group upgraded shares of DocMorris from a “sell” rating to a “neutral” rating in a research report on Monday. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

DocMorris Price Performance

Shares of ZRSEF stock opened at $7.45 on Friday. The firm’s 50-day moving average is $7.45 and its two-hundred day moving average is $7.45. DocMorris has a 12 month low of $7.45 and a 12 month high of $42.50.

About DocMorris

DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes.

The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services.

Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland.